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Abstract
Background: Evidence on the effect of maternal complications in pregnancy on wheezing
in offspring is still insufficient.
Methods: A pooled analysis was performed on individual participant data from fourteen
European birth cohorts to assess the relationship between several maternal pregnancy
complications and wheezing symptoms in the offspring.
Exposures of interest included hypertension and preeclampsia, diabetes, as well as pre-
pregnancy overweight (body mass index between 25 and 29.9) and obesity (body mass
index 30) compared with normal weight (body mass index between 18.5 and 24.9).
Outcomes included both ever and recurrent wheezing from birth up to 12–24 months of
age.
Cohort-specific crude and adjusted risk ratios (RR) were calculated using log-binomial re-
gression models and then pooled using a random effects model.
Results: The study included 85509 subjects. Cohort-specific prevalence of ever wheezing
varied from 20.0% to 47.3%, and of recurrent wheezing from 3.0% to 14.3%. Adjusted
pooled RR for ever and recurrent wheezing were: 1.02 (95% CI: 0.98–1.06) and 1.20 (95%
CI: 0.98–1.47) for hypertensive disorders; 1.09 (95% CI: 1.01–1.18) and 1.23 (95% CI:
1.07–1.43) for preeclampsia; 1.04 (95% CI: 0.97–1.13) and 1.24 (95% CI: 0.86–1.79) for dia-
betes; 1.08 (95% CI: 1.05–1.11) and 1.19 (95% CI: 1.12–1.26) for overweight; 1.12 (95% CI:
1.08–1.17) and 1.16 (95% CI: 0.97–1.39) for obesity. No heterogeneity was found in RR es-
timates among the cohorts, except for diabetes and recurrent wheezing (P¼0.027).
Conclusions: Preeclampsia, maternal pre-pregnancy overweight and obesity are associ-
ated with an increase risk of wheezing in the offspring.
Key words: Pregnancy induced hypertension, Pre-eclampsia, Gestational diabetes, Overweight, Obesity
Introduction
There is growing evidence of a relationship between early
life factors and a wide range of chronic diseases in children
and adults, including obstructive lung diseases and
asthma.1,2 With regard to wheezing and asthma, the
greater influence of maternal vs paternal asthma and atopy
on the development of disease in offspring suggests a role
of the pre- and peri-natal environment.3 Developmental
adaptations in foetal life might result in impaired lung
growth, and subsequently to an increased risk of wheezing
and asthma throughout postnatal life.4
Studies performed in different settings highlighted an
increasing trend in the prevalence of pre-existing and preg-
nancy related pathology, including chronic hypertension,
preeclampsia, diabetes and maternal overweight and obes-
ity.5,6 Relatively few studies have investigated whether
Key Messages
• Maternal hypertensive disorders of pregnancy, including in particular preeclampsia, as well as pre-pregnancy over-
weight and obesity are associated with an increased risk of developing wheezing disorders in early childhood.
• These results add evidence on the relationship between early life factors and wheezing disorders in childhood.”
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maternal complications and conditions in pregnancy are
associated with widely recognized problems such as wheez-
ing and asthma in early childhood, and results are some-
what inconsistent. In a large cross-sectional study Rusconi
et al7 found a relationship between both hypertensive dis-
orders of pregnancy and diabetes in pregnancy and differ-
ent wheezing phenotypes in young children. An association
between maternal hypertension, preeclampsia, and dia-
betes and wheezing/asthma in the first years of life has
been also suggested in one recent birth cohort study8,
whereas earlier studies on maternal hypertensive disorders
revealed mixed findings.9–12
A larger number of studies conducted in prospective
birth cohorts recently found a positive association between
maternal pre-pregnancy obesity and an increase of risk of
wheezing or asthma in infants and young children12–18 and
of asthma symptoms in adolescents.19 In addition, exces-
sive weight gain during pregnancy has been also associated
with wheezing in preschoolers and asthma diagnosis at
school age.7,16
The aim of the present study was to assess the relation-
ship of maternal hypertensive disorders of pregnancy, ma-
ternal diabetes and pre-pregnancy overweight and obesity
with wheezing symptoms developing from birth up to
12–24 months of age in offspring. We conducted an ana-
lysis of maternal complications and conditions pooling
data from several European birth cohorts participating in
the CHICOS (Developing a Child Cohort Research
Strategy for Europe) project (http://www.chicosproject.eu)
to provide robust results across heterogeneous settings and
to have sufficient statistical power even for rare
complications.
Methods
Potential cohorts to be included were identified through
the Environmental Health Risks in European Birth
Cohorts (ENRIECO) inventory (http://www.birthcohort.
net) and through direct contact with researchers participat-
ing in the CHICOS project.
Birth cohorts were eligible if they had started the enroll-
ment after 1990, and if they had suitable information on
maternal complications and conditions in pregnancy and
on wheezing from birth up to 12–24 months of age.
All original cohort studies were approved by their local
Ethical Committee and provided written informed consent
to use their data.
Exposures and outcomes
Exposures of interest were maternal hypertensive disorders
of pregnancy, diabetes and pre-pregnancy maternal
overweight and obesity. Women were considered as af-
fected by hypertensive disorders of pregnancy if they suf-
fered from at least one of the following: chronic
hypertension before pregnancy, hypertension in pregnancy,
preeclampsia or eclampsia. As eclampsia is the end stage of
preeclampsia characterized by generalized seizures and it is
rare, we will use the term preeclampsia hereinafter.
Preeclampsia was additionally studied as an independent
exposure of interest. Maternal diabetes was defined as ei-
ther chronic diabetes before pregnancy or overt diabetes or
glucose intolerance in pregnancy. Overweight and obesity
were defined on the basis of pre-pregnancy body mass
index (BMI), obtained by the ratio of weight (kg) to height
(m)2. Women were defined overweight if their BMI was be-
tween 25 and 29.9 and obese if their BMI was equal or
higher than 30.20 The reference category were women with
BMI between 18.5 and 24.9. Information on exposures of
interest was obtained during pregnancy or at birth by dif-
ferent sources (Table S1, Online Supplementary Data).
We focused on two outcomes of interest: ever wheezing
and recurrent wheezing from birth up to 12–24 months of
age, depending on the time of data collection of each co-
hort. “Ever wheezing” was defined as at least one episode
of wheezing, while “recurrent wheezing” was defined as at
least 4 episodes of wheezing. If the information on number
of episodes 4 was not available, recurrent wheezing was
defined as at least two episodes of wheezing occurring at
different times-span (for example in the first 6 months and
between 6 and 15 months). Information on wheezing
symptoms were obtained from parental questionnaire
(Table S2, Online Supplementary Data).
Statistical analysis
A pooled analysis of fourteen birth cohorts was performed
using a two-stage approach: cohort-specific risk ratios
(RR) with 95% confidence intervals (95% CI) were calcu-
lated using log-binomial regression models and then
pooled using a random effects model21,22. In each pooled
analysis, only the cohorts in which there were at least two
expected events of interest among the exposed, under the
null hypothesis of no effect, were considered.
The following potential confounders were considered:
maternal country of birth, maternal educational level at
child birth, maternal asthma, maternal smoking in preg-
nancy, maternal parity at the index pregnancy, and mater-
nal age at delivery.
RR were first adjusted for the selected confounders
(aRR), then the maternal complications and conditions
were further included in the regression models (mutually
aRR). The mutually aRR for preeclampsia was not ad-
justed for maternal hypertensive disorders of pregnancy.
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Since women may have had more than one pregnancy over
the observational period, robust variance was estimated to
allow for intra-group correlation. All the regression models
were performed on the set of children with no missing data
for any of the outcomes, exposures and confounders.
Several sensitivity analyses were conducted. We per-
formed each pooled analysis by excluding and including
the DNBC cohort because of its large size. Also, potential
effect modification by maternal asthma was evaluated by
introducing an interaction term in the logistic regression
model. Finally, we excluded cohorts for which information
on number of episodes of wheezing (4) was not available
to evaluate the robustness of results.
Statistics were performed using statistical software
STATA 11.1.23
Results
Fourteen cohorts were eligible for the present study and
agreed to participate (Table 1).
The study included 85 509 singleton subjects with avail-
able information on both ever and recurrent wheezing. We
excluded twins from the analysis, as maternal complica-
tions and conditions in pregnancy and outcomes may be
different in twins. Descriptive characteristics of the cohorts
are reported in Table 1 and in Table S3 in the Online
Supplementary Data.
Prevalence of outcome, exposure variables, and poten-
tial confounders differed between cohorts (all tests of
heterogeneity (v2): P< 0.001). Ever wheezing ranged from
20.0% in NINFEA cohort to 47.3% in INMA Sabadell
cohort, while recurrent wheezing ranged from 3.0% in
NINFEA cohort to 14.3% in INMA Valencia cohort.
Maternal hypertensive disorders of pregnancy ranged from
1.7% in INMA Gipuzkoa cohort to 9.4% in DNBC co-
hort, and preeclampsia ranged from 0.9% in INMA
Menorca cohort to 2.9% in Southampton Women’s Survey
cohort. Occurrence of maternal diabetes or glucose intoler-
ance in pregnancy ranged from 0.80% in KOALA cohort
to 19.2% in INMA Sabadell cohort. Prevalence of pre-
pregnancy overweight and obesity ranged from 11.3% and
2.9% in the CoNER cohort to 37.9% and 16.4% in the
EDEN cohort, respectively.
Overall crude RR, aRR and mutually aRR for ever and
recurrent wheezing are reported in Table 2, while cohort-
specific RR are reported in Table S4 and Table S5 in the
Online Supplementary Data. Overall, adjusted estimates
were close to crude estimates, showing a weak confound-
ing effect.
Preeclampsia (mutually aRR, 1.09, 95% CI:
1.01–1.18), maternal pre-pregnancy overweight (mutually
aRR, 1.08, 95% CI: 1.05–1.11) and obesity (mutually
aRR, 1.12, 95% CI: 1.08–1.17) were associated with an
increased risk of ever wheezing (Table S2 and Figure S1,
Online Supplementary Data). The estimated associations
between maternal hypertensive disorders of pregnancy
(mutually aRR, 1.02, 95% CI: 0.98–1.06) or maternal dia-
betes (mutually aRR, 1.04, 95% CI: 0.97–1.13) and ever
wheezing (Figure S1, Online Supplementary Data) were
weaker but consistent with the other maternal complica-
tions and conditions. All estimated values increased
when analyses were conducted on recurrent wheezing,
although confidence intervals were larger. Mutually aRR
for maternal hypertensive disorders of pregnancy was
Table 1. Descriptive characteristics of the fourteen cohorts
Cohort Country Enrolment No of subjects*
Years Developmental period
CoNER Italy 2004–2005 Birth 413
DNBC Denmark 1996–2002 Pregnancy 65 492
EDEN France 2003–2006 Pregnancy 1770
FAROE V Faroes 2007–2009 Birth 418
GASPii Italy 2003–2004 Birth 665
Generation R Netherlands 2001–2006 Pregnancy/birth 5692
Generation XXI Portugal 2005–2006 Pregnancy/birth 992
INMA Gipuzkoa Spain 2006–2008 Pregnancy 547
INMA Menorca Spain 1997–1998 Pregnancy 468
INMA Sabadell Spain 2004–2007 Pregnancy/birth 609
INMA Valencia Spain 2004–2005 Pregnancy 706
KOALA Netherlands 2000–2003 Pregnancy 2654
NINFEA Italy 2005–2011 Pregnancy 1919
Southampton Women’s Survey UK 1998–2002 Pre-pregnancy 2944
*Number of children with information on both ever and recurrent wheezing.
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1.20 (95% CI: 0.98–1.47, Figure 1A), for preeclampsia
was 1.23 (95% CI: 1.07–1.43, Figure 1B), for maternal
diabetes was 1.24 (95% CI: 0.86–1.79, Figure 1C), for ma-
ternal pre-pregnancy overweight was 1.19 (95% CI:
1.12–1.26, Figure 1D) and for obesity was 1.16 (95% CI:
0.97–1.39, Figure 1E).
When excluding DNBC cohort, the main differences in
the estimated RR were observed for the associations be-
tween obesity and ever wheezing (mutually aRR, 1.03,
95% CI: 0.94–1.14), between maternal hypertensive dis-
orders of pregnancy and recurrent wheezing (mutually
aRR, 1.36, 95% CI: 1.10–1.68,) and between preeclamp-
sia and recurrent wheezing (mutually aRR, 1.56, 95% CI:
1.06–2.29). None of the estimated associations, however,
changed direction when the DNBC cohort was excluded
from the analyses.
No evidence of heterogeneity in the mutually aRR esti-
mates was observed, with the exception of the association
between diabetes and recurrent wheezing (P¼ 0.027).
Maternal asthma was not an effect modifier of the associ-
ations found.
When we excluded those cohorts for which information
on number of episodes (>¼4) was not available (CoNER,
GASPii, INMA Menorca, INMA Valencia and NINFEA),
results for recurrent wheezing were similar to those ob-
tained in the complete dataset (Table 2): mutually aRR for
maternal hypertensive disorders of pregnancy: 1.17, 95%
CI: 0.97–1.40; mutually aRR for preeclampsia: 1.31, 95%
CI: 1.04–1.65; mutually aRR for maternal diabetes: 1.04,
95% CI: 0.88–1.24; mutually aRR for overweight, 1.19,
95% CI: 1.12–1.26; mutually aRR for obesity, 1.16, 95%
CI: 0.95–1.41.
Discussion
We investigated the association between selected complica-
tions and conditions in pregnancy and wheezing in the first
two years of life, by combining data of more than 80 000
subjects from 14 birth cohorts in Europe: we found that
hypertensive disorders of pregnancy and in particular pree-
clampsia, and pre-pregnancy overweight and obesity are
associated with an increased risk of developing wheezing
disorders, mainly of recurrent wheezing.
Few and conflicting data on the effect of hypertensive
disorders of pregnancy on wheezing or asthma in off-
spring7–12 were previously observed. Data were particu-
larly scarce on preeclampsia if analysed separately from
hypertension, probably because of the relatively low preva-
lence of the condition (1,4 to 8%, worldwide, with the
highest prevalence in developing countries and in the
USA).24 Two previous studies in Norway and in USA did
not find an association between preeclampsia and asthma
in offspring.11,12
Interestingly Stick et al25 demonstrated that newborn
infants born at term from mothers with hypertension be-
fore or during pregnancy had a reduction of lung function,
similarly to those exposed to maternal smoking in preg-
nancy, which is a well known risk factor for altered pre-
natal lung development. In preeclampsia, a disturbed
regulation of vascular growth in the feto-maternal unit
leads to an overproduction of antiangiogenic factors,
which are markedly increased also in amniotic fluid.24,26
This has been shown to cause sustained abnormalities of
the lung in rat offspring.26 It is therefore possible that pree-
clampsia may alter fetal lung vessel development, predis-
posing offspring to asthma later in life.
Several studies reported positive association between
maternal pre-pregnancy obesity and an increased risk of
Table 2. Overall associations of maternal complications and
conditions in pregnancy and wheezing in childhood
Maternal
complications/conditions
Ever
wheezing
Recurrent
wheezing
Hypertensive disorders % %
No 27.9 8.6
Yes 28.2 9.0
RR (95% CI) 1.05 (0.94–1.17) 1.18 (0.97–1.44)
aRR (95% CI) 1.05 (0.97–1.14) 1.21 (0.99–1.47)
Mutually aRR (95% CI) 1.02 (0.98–1.06) 1.20 (0.98–1.47)
Preeclampsia % %
No 27.9 8.6
Yes 30.5 10.7
RR (95% CI) 1.14 (1.03–1.27) 1.38 (1.07–1.78)
aRR (95% CI) 1.12 (1.04–1.20) 1.31 (1.14–1.51)
Mutually aRR (95% CI) 1.09 (1.01–1.18) 1.23 (1.07–1.43)
Diabetes % %
No 28.1 8.6
Yes 32.5 10.4
RR (95% CI) 1.09 (0.97–1.23) 1.21 (0.90–1.62)
aRR (95% CI) 1.08 (1.00–1.17) 1.19 (0.87–1.64)
Mutually aRR (95% CI) 1.04 (0.97–1.13) 1.24 (0.86–1.79)
Overweight % %
No 27.3 8.0
Yes 30.0 9.8
RR (95% CI) 1.11 (1.05–1.17) 1.24 (1.17–1.31)
aRR (95% CI) 1.08 (1.05–1.11) 1.18 (1.12–1.25)
Mutually aRR (95% CI) 1.08 (1.05–1.11) 1.19 (1.12–1.26)
Obesity % %
No 27.3 8.0
Yes 31.6 11.5
RR (95% CI) 1.11 (1.02–1.21) 1.29 (1.09–1.54)
aRR (95% CI) 1.08 (0.99–1.17) 1.22 (1.05–1.43)
Mutually aRR (95% CI) 1.12 (1.08–1.17) 1.16 (0.97–1.39)
RR¼ relative risk; aRR¼ adjusted relative risk; 95% CI: 95% confidence
interval.
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Figure 1. Associations between several maternal complications in pregnancy and recurrent wheezing in childhood.
A. Hypertensive disorders of pregnancy
B. Maternal preeclampsia
C. Maternal diabetes
D. Maternal pre-pregnancy overweight
E. Maternal pre-pregnancy obesity
ES: Cohort specific and combined mutually adjusted risk ratios; 95% CI: 95% confidence interval; Dþ L: DerSimonian and Laird random-effects
method; I-V: inverse-variance fixed-effects method; I-squared: percentage of between-studies heterogeneity; % weight (Dþ L): set of weights attrib-
uted to each cohort by the random effects analysis.
* SWS: Southampton Women’s Survey
(continued)
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asthma or wheezing in infants and young children.12–16,27
Recently, Pike et al17 found that both pre-pregnancy ma-
ternal BMI and body fat mass were associated with transi-
ent early wheezing but not with persistent wheezing or
asthma in the first 6 years of offspring life. Leermakers
et al18 found an association between maternal obesity and
wheezing at the ages of 1 to 4 years only in offspring with
a maternal history of asthma or atopy. Potential biological
mechanisms underlying this association are still unclear.
Furthermore, because maternal and offspring weight are
correlated28 and previous studies have shown that obesity
in young children29 and weight gain acceleration in early
infancy30 are associated with increased risks of asthma
symptoms and impaired lung development in infancy31, it
Figure 1. Continued.
International Journal of Epidemiology, 2015, Vol. 44, No. 1 205
Downloaded from https://academic.oup.com/ije/article-abstract/44/1/199/657806
by guest
on 06 August 2018
is possible that child weight/weight gain may account at
least for a part of the association found.
We did not find an association between maternal dia-
betes and ever wheezing up to 12–24 months of life, al-
though for recurrent wheezing we obtained an aRR of 1.25
(95% CI: 0.86–1.79). Prevalence of maternal diabetes was
quite different among the cohorts, reflecting both the well-
known higher prevalence in Northern compared to
Southern Europe and the heterogeneities in screening prac-
tice and policy.32 In a cross sectional study on a large num-
ber of children maternal diabetes (before or during
pregnancy) was associated with persistent wheezing at 6
years of life (OR: 1.84; 99% CI: 1.06–3.20).7 More re-
cently Risnes et al8 in a birth cohort study found that ma-
ternal diabetes was associated with increased asthma risk
in 6 year old children (OR¼ 3.63, 95% CI: 1.46–9.04).
Further evaluation is needed to confirm these associations
and to explain the underlying biological mechanisms.
Adjusting for birth weight or gestational duration, or
other perinatal or postnatal factors, in regression models is
a common approach to estimate the associations between
complications or conditions in pregnancy and a health out-
come in the offspring. However, in many scenarios, rather
than being true confounders, these variables act as poten-
tial mediators. Accordingly, in our study we assumed that
birth weight, gestational duration, mode of delivery, and
also breastfeeding were potential mediators in the pathway
between hypertensive disorders of pregnancy, diabetes,
overweight/obesity and wheezing. Since we were primarily
interested in the total effect of maternal complications and
not in studying to what extent these effects are explained
by potential mediators, we did not adjust for these medi-
ators. In addition, as repeatedly discussed and empirically
verified33–35, adjustment for these variables would have
also introduced a spurious association between the expos-
ure and the outcome (so called collider bias) in the
presence of unmeasured variables that confound the medi-
ator-outcome relationship. Had our approach of treating
birth weight, gestational duration, mode of delivery, and
breastfeeding as potential mediators been incorrect, our
results would have been affected potentially by confound-
ing bias from these variables. To test the potential impact
of this bias we carried out models adjusting for these vari-
ables and found that the relative risk estimates for all
exposures of interest were only moderately changed after
adjustment (data not shown). The largest change in esti-
mate was found for diabetes, with a relative risk for recur-
rent wheezing of 1.17 (95% CI: 0.95,1.45) when adjusting
for birth weight, gestational duration, mode of delivery
and breastfeeding versus a relative risk of 1.24 (95%
CI: 0.86,1.79) without adjustment (Table 2).
Pooling data from several cohorts and hence providing
strong statistical power and robust results is the greatest
strength of our study. This also enables us to compare
Figure 1. Continued.
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results among different European birth cohorts; absence of
heterogeneity in the associations suggests that residual con-
founding is an unlikely explanation for our findings.
As expected, there was variability in the distribution of
maternal complications, confounders and outcomes among
the cohorts. Besides a true differential distribution, the
observed variability may also be due to differences in the
study design, selection of the population, as well as to
wording and timing of the questions. Furthermore, collec-
tion of the exposures of interest, although conducted at lat-
est at birth, relied on different sources, and above all,
ascertainment of complications (e.g. diabetes in pregnancy)
might be different in different countries and, as already dis-
cussed, might have inherent problems.32 Some cohorts lack
data on hypertension and diabetes before pregnancy; how-
ever this would probably change the prevalence of these
disorders in pregnancy very little, as women chronically af-
fected by these diseases have a high probability to be diag-
nosed in pregnancy. Prevalence of ever and especially
recurrent wheezing were not directly comparable among
cohorts: this again could be in part a true difference but
could also be due to different time-points at which the in-
formation was collected and to the lack of information on
exact number of wheezing episodes in some cohorts. In
spite of all these sources of variability, we found fairly
homogeneous effects across the different cohorts, indicat-
ing that our results are robust.
The collected information is mainly questionnaire-based
and self-reported, therefore misclassification is possible, al-
though in larger cohorts information on maternal compli-
cations were obtained by obstetric records or link with
routine data-bases (Supplementary data). However, meas-
urement of exposure prior to outcome suggests that
the within study bias in exposure assessments is non-
differential with respect to outcome, and it is expected to
make our estimates conservative. Furthermore, some of the
exposures investigated in our study, and especially pree-
clampsia, are well-defined conditions, for which we expect
a minimal role for misclassification. Maternal reports of
wheezing, although widely accepted in epidemiological
studies, might overestimate the presence of the condition,
in particular for ever wheezing, as parents might label as
wheezing an isolated episode of noisy breathing.36
Recurrent wheezing is less affected by this source of bias
and is more likely to configure a pathological condition;
consistently, associations were larger when we studied re-
current instead of ever wheezing.
We only studied children under two years, and follow
up studies at older ages are needed in order to clarify the
contribution of these maternal factors to wheezing persist-
ing into school age, and to a diagnosis of asthma. It is well
known that in most cases wheeze is a transient condition
and the majority resolves during the first few years of
childhood. However, young children with wheezing, espe-
cially if recurrent, consume a disproportionately high
amount of health care resources36. Furthermore, longitu-
dinal studies have shown that about 25% of children with
persistent asthma start to wheeze in the first 6 months of
age, and up to 75% by the age of three years.36 Wheezing
of early onset has been also associated with a congenital
impairment of lung function that may track into adult life
in susceptible individuals and that might predispose them
to chronic respiratory diseases.1
Supplementary Data
Supplementary data are available at IJE online.
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